CN101953999B - Medicinal composition for treating paralysis and preparation method thereof - Google Patents

Medicinal composition for treating paralysis and preparation method thereof Download PDF

Info

Publication number
CN101953999B
CN101953999B CN2010105124820A CN201010512482A CN101953999B CN 101953999 B CN101953999 B CN 101953999B CN 2010105124820 A CN2010105124820 A CN 2010105124820A CN 201010512482 A CN201010512482 A CN 201010512482A CN 101953999 B CN101953999 B CN 101953999B
Authority
CN
China
Prior art keywords
weight portion
radix
weight
rhizoma
portions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010105124820A
Other languages
Chinese (zh)
Other versions
CN101953999A (en
Inventor
张洪涛
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105124820A priority Critical patent/CN101953999B/en
Publication of CN101953999A publication Critical patent/CN101953999A/en
Application granted granted Critical
Publication of CN101953999B publication Critical patent/CN101953999B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses a medicinal composition for treating paralysis. The medicinal composition consists of Chinese medicaments such as common monkshood mother root, kusnezoff monkshood root, centipede, arisaema root, tall gastrodia tuber, angelica dahurica, nutgrass galingale rhizome, scrophularia root and the like. The traditional black plaster is used as matrix in the medicinal composition, the medicinal composition stimulates the nerve ending by using the transdermal absorption mechanism, and the blood vessels are expanded to promote local blood circulation and improve the nutrition of surrounding tissues. Meanwhile, after penetrating the skin and the mucous membrane, the medicament enters systemic circulation through the blood vessels or lymphatic vessels to generate systemic medicament effect and fulfill the purpose of treating diseases. The medicinal composition avoids sequela caused by treating the paralysis with hemiplegia cream, avoids the defect of curing the symptoms, not the disease in the physical therapy, meanwhile avoids injury to livers and kidneys of patients, and achieves good effect on clinical application.

Description

A kind of pharmaceutical composition of treating paralysis and preparation method thereof
Technical field
The present invention relates to a kind of pharmaceutical composition, particularly relate to a kind of pharmaceutical composition of treating paralysis and preparation method thereof
Background technology
Paralysis (paralysis) is the attenuating or the forfeiture of voluntary motor function, and its sequela is: quadriplegia, facial hemiparalysis, numb limbs and tense tendons consequently can't take care of oneself, and bring very big misery to patient.To this sick pathogeny, the traditional Chinese medical science is thought: hemiplegia belongs to the apoplexy category more, and because of insufficiency of vital energy and blood, deficiency of vital energy blood is capable not smooth, and pulse classic is hollow, and brains lose supports, the event of the stagnant meridians of turbid stagnation of phlegm.Doctor trained in Western medicine thinks that then this cause of disease cerebral infarction, cerebral arteriosclerosis cause the cerebral tissue blood supply insufficiency, causes anoxia, ischemia, thus nerve, mental symptom that brain hypofunction is occurred.In treatment, though physiotherapy can be improved sign, help restore funcitons, waste time and energy, have little effect; Doctor trained in Western medicine then can only have mitigation to acute stage to this sick treatment, and is very little to the sequela curative effect, and the many livers to patient of medicine, renal function are caused certain infringement.
Summary of the invention
The object of the present invention is to provide a kind of pharmaceutical composition of treating paralysis.
Another object of the present invention is to provide this preparation of drug combination method.
The present invention realizes through following technical scheme:
Radix Aconiti 5-25 weight portion Radix Aconiti Kusnezoffii 5-25 weight portion Scolopendra 5-25 weight portion
Rhizoma Arisaematis 5-25 weight portion Rhizoma Gastrodiae 5-25 weight portion Radix Angelicae Dahuricae 5-25 weight portion
The black ginseng of Rhizoma Cyperi 5-25 weight portion 5-25 weight portion Fructus Gardeniae 5-25 weight portion
Fructus Aurantii 5-25 weight portion Radix Et Rhizoma Rhei 5-25 weight portion Radix Linderae 5-25 weight portion
Radix Peucedani 5-25 weight portion Fructus Atriplicis Sibiricae 5-25 weight portion Radix Bupleuri 5-25 weight portion
Bulbus Fritillariae Cirrhosae 5-25 weight portion Rhizoma Cimicifugae 5-25 weight portion Rhizoma Chuanxiong 5-25 weight portion
Pericarpium Citri Reticulatae Viride 5-25 weight portion Radix Achyranthis Bidentatae 5-25 weight portion Radix Clematidis 5-25 weight portion
Rhizoma Atractylodis 5-25 weight portion Cortex Eucommiae 5-25 weight portion Radix Rehmanniae 5-25 weight portion
Herba Asari 5-25 weight portion Radix Rehmanniae Preparata 5-25 weight portion Rhizoma Anemarrhenae 5-25 weight portion
Radix Polygalae 5-25 weight portion Radix Angelicae Sinensis 5-25 weight portion Herba Menthae 5-25 weight portion
Herba Artemisiae Scopariae 5-25 weight portion Cortex Dictamni 5-25 weight portion Rhizoma Atractylodis Macrocephalae 5-25 weight portion
Semen Armeniacae Amarum 5-25 weight portion Rhizoma Et Radix Notopterygii 5-25 weight portion Cortex Acanthopancis 5-25 weight portion
Rhizoma Pinelliae 5-25 weight portion Cortex Mori 5-25 weight portion Radix Angelicae Pubescentis 5-25 weight portion
Ramulus Salicis Babylonicae 5-25 weight portion Caulis Akebiae 5-25 weight portion Radix Sanguisorbae 5-25 weight portion
The windproof 5-25 weight portion of Chinese toon branch 5-25 weight portion Ramulus Broussonetiae 5-25 weight portion
Radix Astragali 5-25 weight portion Squama Manis 5-25 weight portion.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti 15 weight portion Radix Aconiti Kusnezoffii 15 weight portion Scolopendras 15 weight portions
The Rhizoma Arisaematis 15 weight portion Rhizoma Gastrodiaes 15 weight portion Radixs Angelicae Dahuricae 15 weight portions
The black ginseng of Rhizoma Cyperi 15 weight portions 15 weight portion Fructus Gardeniaes 15 weight portions
The Fructus Aurantii 15 weight portion Radix Et Rhizoma Rhei 15 weight portion Radixs Linderae 15 weight portions
Radix Peucedani 15 weight portion Fructus Atriplicis Sibiricaees 15 weight portion Radix Bupleuri 15 weight portions
Bulbus Fritillariae Cirrhosae 15 weight portion Rhizoma Cimicifugaes 15 weight portion Rhizoma Chuanxiongs 15 weight portions
Pericarpium Citri Reticulatae Viride 15 weight portion Radix Achyranthis Bidentataes 15 weight portion Radix Clematidis 15 weight portions
The Rhizoma Atractylodis 15 weight portion Cortexs Eucommiae 15 weight portion Radix Rehmanniae 15 weight portions
The Herba Asari 15 weight portion Radix Rehmanniaes Preparata 15 weight portion Rhizoma Anemarrhenaes 15 weight portions
Radix Polygalae 15 weight portion Radix Angelicae Sinensis 15 weight portion Herba Menthaes 15 weight portions
The Herba Artemisiae Scopariae 15 weight portion Cortex Dictamni 15 weight portion Rhizoma Atractylodis Macrocephalaes 15 weight portions
Semen Armeniacae Amarum 15 weight portion Rhizoma Et Radix Notopterygiis 15 weight portion Cortex Acanthopanciss 15 weight portions
The Rhizoma Pinelliae 15 weight portion Cortex Mori 15 weight portion Radix Angelicae Pubescentiss 15 weight portions
Ramulus Salicis Babylonicae 15 weight portion Caulis Akebiaes 15 weight portion Radix Sanguisorbaes 15 weight portions
Windproof 15 weight portions of Chinese toon branch 15 weight portion Ramulus Broussonetiae 15 weight portions
The Radix Astragali 15 weight portion Squama Maniss 15 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti 7 weight portion Radix Aconiti Kusnezoffii 22 weight portion Scolopendras 7 weight portions
The Rhizoma Arisaematis 22 weight portion Rhizoma Gastrodiaes 7 weight portion Radixs Angelicae Dahuricae 22 weight portions
The black ginseng of Rhizoma Cyperi 7 weight portions 22 weight portion Fructus Gardeniaes 7 weight portions
The Fructus Aurantii 22 weight portion Radix Et Rhizoma Rhei 7 weight portion Radixs Linderae 22 weight portions
Radix Peucedani 7 weight portion Fructus Atriplicis Sibiricaees 22 weight portion Radix Bupleuri 7 weight portions
Bulbus Fritillariae Cirrhosae 22 weight portion Rhizoma Cimicifugaes 7 weight portion Rhizoma Chuanxiongs 22 weight portions
Pericarpium Citri Reticulatae Viride 7 weight portion Radix Achyranthis Bidentataes 22 weight portion Radix Clematidis 7 weight portions
The Rhizoma Atractylodis 22 weight portion Cortexs Eucommiae 7 weight portion Radix Rehmanniae 22 weight portions
The Herba Asari 7 weight portion Radix Rehmanniaes Preparata 22 weight portion Rhizoma Anemarrhenaes 7 weight portions
Radix Polygalae 22 weight portion Radix Angelicae Sinensis 7 weight portion Herba Menthaes 22 weight portions
The Herba Artemisiae Scopariae 7 weight portion Cortex Dictamni 22 weight portion Rhizoma Atractylodis Macrocephalaes 7 weight portions
Semen Armeniacae Amarum 22 weight portion Rhizoma Et Radix Notopterygiis 7 weight portion Cortex Acanthopanciss 22 weight portions
The Rhizoma Pinelliae 7 weight portion Cortex Mori 22 weight portion Radix Angelicae Pubescentiss 7 weight portions
Ramulus Salicis Babylonicae 22 weight portion Caulis Akebiaes 7 weight portion Radix Sanguisorbaes 22 weight portions
Windproof 7 weight portions of Chinese toon branch 7 weight portion Ramulus Broussonetiae 22 weight portions
The Radix Astragali 22 weight portion Squama Maniss 7 weight portions.
The crude drug composition of pharmaceutical composition of the present invention is preferably:
Radix Aconiti 20 weight portion Radix Aconiti Kusnezoffii 10 weight portion Scolopendras 20 weight portions
The Rhizoma Arisaematis 10 weight portion Rhizoma Gastrodiaes 20 weight portion Radixs Angelicae Dahuricae 10 weight portions
The black ginseng of Rhizoma Cyperi 20 weight portions 10 weight portion Fructus Gardeniaes 20 weight portions
The Fructus Aurantii 10 weight portion Radix Et Rhizoma Rhei 20 weight portion Radixs Linderae 10 weight portions
Radix Peucedani 20 weight portion Fructus Atriplicis Sibiricaees 10 weight portion Radix Bupleuri 20 weight portions
Bulbus Fritillariae Cirrhosae 10 weight portion Rhizoma Cimicifugaes 20 weight portion Rhizoma Chuanxiongs 10 weight portions
Pericarpium Citri Reticulatae Viride 20 weight portion Radix Achyranthis Bidentataes 10 weight portion Radix Clematidis 20 weight portions
The Rhizoma Atractylodis 10 weight portion Cortexs Eucommiae 20 weight portion Radix Rehmanniae 10 weight portions
The Herba Asari 20 weight portion Radix Rehmanniaes Preparata 10 weight portion Rhizoma Anemarrhenaes 20 weight portions
Radix Polygalae 10 weight portion Radix Angelicae Sinensis 20 weight portion Herba Menthaes 10 weight portions
The Herba Artemisiae Scopariae 20 weight portion Cortex Dictamni 10 weight portion Rhizoma Atractylodis Macrocephalaes 20 weight portions
Semen Armeniacae Amarum 10 weight portion Rhizoma Et Radix Notopterygiis 20 weight portion Cortex Acanthopanciss 10 weight portions
The Rhizoma Pinelliae 20 weight portion Cortex Mori 10 weight portion Radix Angelicae Pubescentiss 20 weight portions
Ramulus Salicis Babylonicae 10 weight portion Caulis Akebiaes 20 weight portion Radix Sanguisorbaes 10 weight portions
Windproof 20 weight portions of Chinese toon branch 20 weight portion Ramulus Broussonetiae 10 weight portions
The Radix Astragali 10 weight portion Squama Maniss 20 weight portions.
Pharmaceutical composition of the present invention adds the exterior-applied formulation that conventional adjuvant is processed clinical acceptance by practice of pharmacy, like black unguentum, ointment, emplastrum, cataplasma, rubber-emplastrum or powder.
The present invention " left side paralysed right paralysis cream " is a substrate with the traditional black plaster, utilizes Transdermal absorption mechanism, makes these article tip that excites nerve, and through reflection, blood vessel dilating promotes local blood circulation, improves surrounding tissue nutrition.Simultaneously, behind medicine break-through skin and the mucosa, get into the body circulation, can produce the systemic medication effect, reach the purpose of treatment disease through blood vessel or lymphatic vessel.The sequela that adopts the paralysed right paralysis cream treatment paralysis in a left side to bring, the drawback of having avoided physiotherapy to cure the symptoms, not the disease has also been avoided infringement that patient's Liver and kidney is caused simultaneously, in clinical practice, has obtained good effect.
Following experimental example is used to further specify the present invention but is not limited to the present invention.
Experimental example:
One, physical data
Randomly draw clinical case 50 examples, male 40 examples, women 10 examples; At 52~71 years old age, 53 years old mean age, the course of disease is the longest 6 years, and is the shortest 3 months.
Two, criterion of therapeutical effect
Because of primary disease does not still have clear and definite standard at present, so according to The clinical experience, to treat the variation result of determination of back symptom, sign index.
Basically recover: transference cure, functional activity recover normal;
Produce effects: transference cure or cardinal symptom disappear, and function is recovered normally can take care of oneself, work basically;
Effectively: sx or disappearance, sign takes a turn for the better, but can't take care of oneself fully, work;
Invalid: symptom, the equal no change of sign.
Three, Therapeutic Method
Scheme 1:
1, medicine is formed:
Radix Aconiti 15g; Radix Aconiti Kusnezoffii 15g; Scolopendra 15g; Rhizoma Arisaematis 15g; Rhizoma Gastrodiae 15g; Radix Angelicae Dahuricae 15g; Rhizoma Cyperi 15g; Black ginseng 15g; Fructus Gardeniae 15g; Fructus Aurantii 15g; Radix Et Rhizoma Rhei 15g; Radix Linderae 15g; Radix Peucedani 15g; Fructus Atriplicis Sibiricae 15g; Radix Bupleuri 15g; Bulbus Fritillariae Cirrhosae 15g; Rhizoma Cimicifugae 15g; Rhizoma Chuanxiong 15g; Pericarpium Citri Reticulatae Viride 15g; Radix Achyranthis Bidentatae 15g; Radix Clematidis 15g; Rhizoma Atractylodis 15g; Cortex Eucommiae 15g; Radix Rehmanniae 15g; Herba Asari 15g; Radix Rehmanniae Preparata 15g; Rhizoma Anemarrhenae 15g; Radix Polygalae 15g; Radix Angelicae Sinensis 15g; Herba Menthae 15g; Herba Artemisiae Scopariae 15g; Cortex Dictamni 15g; Rhizoma Atractylodis Macrocephalae 15g; Semen Armeniacae Amarum 15g; Rhizoma Et Radix Notopterygii 15g; Cortex Acanthopancis 15g; Rhizoma Pinelliae 15g; Cortex Mori 15g; Radix Angelicae Pubescentis 15g; Ramulus Salicis Babylonicae 15g; Caulis Akebiae 15g; Radix Sanguisorbae 15g; Chinese toon branch 15g; Ramulus Broussonetiae 15g; Windproof 15g; Radix Astragali 15g; Squama Manis 15g.
2, method for preparing:
The above-mentioned raw materials medicine adds the black unguentum that conventional adjuvant is processed clinical acceptance by practice of pharmacy, and every part of 5g sticks in the affected part.
3, Therapeutic Method:
Earlier patient's joint part is used the warm water scrub during treatment, stick with the black unguentum of the present invention, changed dressings 1 time in per 48 hours, 6 days is a course of treatment, and a situation arises to observe untoward reaction during the medication.
Scheme 2:
1, medicine is formed:
Radix Aconiti 7g; Radix Aconiti Kusnezoffii 22g; Scolopendra 7g; Rhizoma Arisaematis 22g; Rhizoma Gastrodiae 7g; Radix Angelicae Dahuricae 22g; Rhizoma Cyperi 7g; Black ginseng 22g; Fructus Gardeniae 7g; Fructus Aurantii 22g; Radix Et Rhizoma Rhei 7g; Radix Linderae 22g; Radix Peucedani 7g; Fructus Atriplicis Sibiricae 22g; Radix Bupleuri 7g; Bulbus Fritillariae Cirrhosae 22g; Rhizoma Cimicifugae 7g; Rhizoma Chuanxiong 22g; Pericarpium Citri Reticulatae Viride 7g; Radix Achyranthis Bidentatae 22g; Radix Clematidis 7g; Rhizoma Atractylodis 22g; Cortex Eucommiae 7g; Radix Rehmanniae 22g; Herba Asari 7g; Radix Rehmanniae Preparata 22g; Rhizoma Anemarrhenae 7g; Radix Polygalae 22g; Radix Angelicae Sinensis 7g; Herba Menthae 22g; Herba Artemisiae Scopariae 7g; Cortex Dictamni 22g; Rhizoma Atractylodis Macrocephalae 7g; Semen Armeniacae Amarum 22g; Rhizoma Et Radix Notopterygii 7g; Cortex Acanthopancis 22g; Rhizoma Pinelliae 7g; Cortex Mori 22g; Radix Angelicae Pubescentis 7g; Ramulus Salicis Babylonicae 22g; Caulis Akebiae 7g; Radix Sanguisorbae 22g; Chinese toon branch 7g; Ramulus Broussonetiae 22g; Windproof 7g; Radix Astragali 22g; Squama Manis 7g.
2, method for preparing:
The above-mentioned raw materials medicine adds the emplastrum that conventional adjuvant is processed clinical acceptance by practice of pharmacy, and every part of 5g sticks in the affected part.
3, Therapeutic Method:
Earlier patient's joint part is used the warm water scrub during treatment, stick with emplastrum of the present invention, changed dressings 1 time in per 48 hours, 6 days is a course of treatment, and a situation arises to observe untoward reaction during the medication.
Scheme 3:
1, medicine is formed:
Radix Aconiti 20g; Radix Aconiti Kusnezoffii 10g; Scolopendra 20g; Rhizoma Arisaematis 10g; Rhizoma Gastrodiae 20g; Radix Angelicae Dahuricae 10g; Rhizoma Cyperi 20g; Black ginseng 10g; Fructus Gardeniae 20g; Fructus Aurantii 10g; Radix Et Rhizoma Rhei 20g; Radix Linderae 10g; Radix Peucedani 20g; Fructus Atriplicis Sibiricae 10g; Radix Bupleuri 20g; Bulbus Fritillariae Cirrhosae 10g; Rhizoma Cimicifugae 20g; Rhizoma Chuanxiong 10g; Pericarpium Citri Reticulatae Viride 20g; Radix Achyranthis Bidentatae 10g; Radix Clematidis 20g; Rhizoma Atractylodis 10g; Cortex Eucommiae 20g; Radix Rehmanniae 10g; Herba Asari 20g; Radix Rehmanniae Preparata 10g; Rhizoma Anemarrhenae 20g; Radix Polygalae 10g; Radix Angelicae Sinensis 20g; Herba Menthae 10g; Herba Artemisiae Scopariae 20g; Cortex Dictamni 10g; Rhizoma Atractylodis Macrocephalae 20g; Semen Armeniacae Amarum 10g; Rhizoma Et Radix Notopterygii 20g; Cortex Acanthopancis 10g; Rhizoma Pinelliae 20g; Cortex Mori 10g; Radix Angelicae Pubescentis 20g; Ramulus Salicis Babylonicae 10g; Caulis Akebiae 20g; Radix Sanguisorbae 10g; Chinese toon branch 20g; Ramulus Broussonetiae 10g; Windproof 20g; Radix Astragali 10g; Squama Manis 20g.
2, method for preparing:
The above-mentioned raw materials medicine adds the ointment that conventional adjuvant is processed clinical acceptance by practice of pharmacy, and every part of 5g sticks in the affected part.
3, Therapeutic Method:
Earlier patient's joint part is used the warm water scrub during treatment, stick with ointment of the present invention, changed dressings 1 time in per 48 hours, 6 days is a course of treatment, and a situation arises to observe untoward reaction during the medication.
Four, therapeutic outcome:
Clinical case 50 examples are through treating 23 examples of recovering basically (accounting example 46%); Produce effects 12 examples (accounting example 24%); Effective 10 examples (accounting example 20%); Invalid 5 examples (accounting example 10%).Total effective rate is 90%, does not find obvious adverse reaction during the medication.
Five, model case
Case 1: Zhao, man, 66 years old, the kind all village people of stockaded village in Hua County, Henan Province, retired cadre.
Cerebral hemorrhage in 2008, after hospitalize, left side upper limb flexing, lower limb are stiff.Adopt General Physics therapy and a lot of Western medicine on probation, curative effect is very little.Come to go to a doctor in March, 2010, two courses of treatment of the application embodiment of the invention 1 black unguentum, the sensation limbs begin to regain consciousness, and after five courses of treatment, can uprightly walk or drive slowly.Continue medication and be aided with physiotherapy, recovered normal now basically.
Case 2: Mulberry so-and-so, woman, 50 years old, Yuanyang, Henan Province people from city, housewife.
Apoplectic hemiplegia in 2007 can't take care of oneself.Went to a doctor before in May, 2009, two courses of treatment of the application embodiment of the invention 3 emplastrumes, the sensation curative effect is not too obvious.Three courses of treatment of application to the, the sensation leg muscle is strong.After application six courses of treatment, have clear improvement.Continue medication and also be aided with physiotherapy, can independent ambulation, hold thing.
Following embodiment all can realize the effect of above-mentioned experimental example.
The specific embodiment
Embodiment 1:
Radix Aconiti 15kg Radix Aconiti Kusnezoffii 15kg Scolopendra 15kg Rhizoma Arisaematis 15kg
The black ginseng of Rhizoma Gastrodiae 15kg Radix Angelicae Dahuricae 15kg Rhizoma Cyperi 15kg 15kg
Fructus Gardeniae 15kg Fructus Aurantii 15kg Radix Et Rhizoma Rhei 15kg Radix Linderae 15kg
Radix Peucedani 15kg Fructus Atriplicis Sibiricae 15kg Radix Bupleuri 15kg Bulbus Fritillariae Cirrhosae 15kg
Rhizoma Cimicifugae 15kg Rhizoma Chuanxiong 15kg Pericarpium Citri Reticulatae Viride 15kg Radix Achyranthis Bidentatae 15kg
Radix Clematidis 15kg Rhizoma Atractylodis 15kg Cortex Eucommiae 15kg Radix Rehmanniae 15kg
Herba Asari 15kg Radix Rehmanniae Preparata 15kg Rhizoma Anemarrhenae 15kg Radix Polygalae 15kg
Radix Angelicae Sinensis 15kg Herba Menthae 15kg Herba Artemisiae Scopariae 15kg Cortex Dictamni 15kg
Rhizoma Atractylodis Macrocephalae 15kg Semen Armeniacae Amarum 15kg Rhizoma Et Radix Notopterygii 15kg Cortex Acanthopancis 15kg
Rhizoma Pinelliae 15kg Cortex Mori 15kg Radix Angelicae Pubescentis 15kg Ramulus Salicis Babylonicae 15kg
Caulis Akebiae 15kg Radix Sanguisorbae 15kg Chinese toon branch 15kg Ramulus Broussonetiae 15kg
Windproof 15kg Radix Astragali 15kg Squama Manis 15kg.
The above-mentioned raw materials medicine adds the black unguentum that conventional adjuvant is processed clinical acceptance, every part of 5g by practice of pharmacy.Earlier patient's joint part is used the warm water scrub during treatment, stick with unguentum, changed dressings 1 time in per 48 hours, 6 days is a course of treatment.
Embodiment 2:
Radix Aconiti 7kg Radix Aconiti Kusnezoffii 22kg Scolopendra 7kg Rhizoma Arisaematis 22kg
The black ginseng of Rhizoma Gastrodiae 7kg Radix Angelicae Dahuricae 22kg Rhizoma Cyperi 7kg 22kg
Fructus Gardeniae 7kg Fructus Aurantii 22kg Radix Et Rhizoma Rhei 7kg Radix Linderae 22kg
Radix Peucedani 7kg Fructus Tribuli 22kg Radix Bupleuri 7kg Bulbus Fritillariae Cirrhosae 22kg
Rhizoma Cimicifugae 7kg Rhizoma Chuanxiong 22kg Pericarpium Citri Reticulatae Viride 7kg Radix Achyranthis Bidentatae 22kg
Radix Clematidis 7kg Rhizoma Atractylodis 22kg Cortex Eucommiae 7kg Radix Rehmanniae 22kg
Herba Asari 7kg Radix Rehmanniae Preparata 22kg Rhizoma Anemarrhenae 7kg Radix Polygalae 22kg
Radix Angelicae Sinensis 7kg Herba Menthae 22kg Herba Artemisiae Scopariae 7kg Cortex Dictamni 22kg
Rhizoma Atractylodis Macrocephalae 7kg Semen Armeniacae Amarum 22kg Rhizoma Et Radix Notopterygii 7kg Cortex Acanthopancis 22kg
Rhizoma Pinelliae 7kg Cortex Mori 22kg Radix Angelicae Pubescentis 7kg Ramulus Salicis Babylonicae 22kg
Caulis Akebiae 7kg Radix Sanguisorbae 22kg Chinese toon branch 7kg Ramulus Broussonetiae 22kg
Windproof 7kg Radix Astragali 22kg Squama Manis 7kg.
The above-mentioned raw materials medicine is processed the ointment of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.
Embodiment 3:
Radix Aconiti 20kg Radix Aconiti Kusnezoffii 10kg Scolopendra 20kg Rhizoma Arisaematis 10kg
The black ginseng of Rhizoma Gastrodiae 20kg Radix Angelicae Dahuricae 10kg Rhizoma Cyperi 20kg 10kg
Fructus Gardeniae 20kg Fructus Aurantii 10kg Radix Et Rhizoma Rhei 20kg Radix Linderae 10kg
Radix Peucedani 20kg Fructus Atriplicis Sibiricae 10kg Radix Bupleuri 20kg Bulbus Fritillariae Cirrhosae 10kg
Rhizoma Cimicifugae 20kg Rhizoma Chuanxiong 10kg Pericarpium Citri Reticulatae Viride 20kg Radix Achyranthis Bidentatae 10kg
Radix Clematidis 20kg Rhizoma Atractylodis 10kg Cortex Eucommiae 20kg Radix Rehmanniae 10kg
Herba Asari 20kg Radix Rehmanniae Preparata 10kg Rhizoma Anemarrhenae 20kg Radix Polygalae 10kg
Radix Angelicae Sinensis 20kg Herba Menthae 10kg Herba Artemisiae Scopariae 20kg Cortex Dictamni 10kg
Rhizoma Atractylodis Macrocephalae 20kg Semen Armeniacae Amarum 10kg Rhizoma Et Radix Notopterygii 20kg Cortex Acanthopancis 10kg
Rhizoma Pinelliae 20kg Cortex Mori 10kg Radix Angelicae Pubescentis 20kg Ramulus Salicis Babylonicae 10kg
Caulis Akebiae 20kg Radix Sanguisorbae 10kg Chinese toon branch 20kg Ramulus Broussonetiae 10kg
Windproof 20kg Radix Astragali 10kg Squama Manis 20kg.
The above-mentioned raw materials medicine is processed the emplastrum of clinical acceptance according to the conventional adjuvant that common process adds on the pharmaceutics.

Claims (8)

1. pharmaceutical composition of treating paralysis is characterized in that the crude drug of this pharmaceutical composition consists of:
Radix Aconiti 5-25 weight portion Radix Aconiti Kusnezoffii 5-25 weight portion Scolopendra 5-25 weight portion
Rhizoma Arisaematis 5-25 weight portion Rhizoma Gastrodiae 5-25 weight portion Radix Angelicae Dahuricae 5-25 weight portion
The black ginseng of Rhizoma Cyperi 5-25 weight portion 5-25 weight portion Fructus Gardeniae 5-25 weight portion
Fructus Aurantii 5-25 weight portion Radix Et Rhizoma Rhei 5-25 weight portion Radix Linderae 5-25 weight portion
Radix Peucedani 5-25 weight portion Fructus Atriplicis Sibiricae 5-25 weight portion Radix Bupleuri 5-25 weight portion
Bulbus Fritillariae Cirrhosae 5-25 weight portion Rhizoma Cimicifugae 5-25 weight portion Rhizoma Chuanxiong 5-25 weight portion
Pericarpium Citri Reticulatae Viride 5-25 weight portion Radix Achyranthis Bidentatae 5-25 weight portion Radix Clematidis 5-25 weight portion
Rhizoma Atractylodis 5-25 weight portion Cortex Eucommiae 5-25 weight portion Radix Rehmanniae 5-25 weight portion
Herba Asari 5-25 weight portion Radix Rehmanniae Preparata 5-25 weight portion Rhizoma Anemarrhenae 5-25 weight portion
Radix Polygalae 5-25 weight portion Radix Angelicae Sinensis 5-25 weight portion Herba Menthae 5-25 weight portion
Herba Artemisiae Scopariae 5-25 weight portion Cortex Dictamni 5-25 weight portion Rhizoma Atractylodis Macrocephalae 5-25 weight portion
Semen Armeniacae Amarum 5-25 weight portion Rhizoma Et Radix Notopterygii 5-25 weight portion Cortex Acanthopancis 5-25 weight portion
Rhizoma Pinelliae 5-25 weight portion Cortex Mori 5-25 weight portion Radix Angelicae Pubescentis 5-25 weight portion
Ramulus Salicis Babylonicae 5-25 weight portion Caulis Akebiae 5-25 weight portion Radix Sanguisorbae 5-25 weight portion
The windproof 5-25 weight portion of Chinese toon branch 5-25 weight portion Ramulus Broussonetiae 5-25 weight portion
Radix Astragali 5-25 weight portion Squama Manis 5-25 weight portion.
2. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Radix Aconiti 15 weight portion Radix Aconiti Kusnezoffii 15 weight portion Scolopendras 15 weight portions
The Rhizoma Arisaematis 15 weight portion Rhizoma Gastrodiaes 15 weight portion Radixs Angelicae Dahuricae 15 weight portions
The black ginseng of Rhizoma Cyperi 15 weight portions 15 weight portion Fructus Gardeniaes 15 weight portions
The Fructus Aurantii 15 weight portion Radix Et Rhizoma Rhei 15 weight portion Radixs Linderae 15 weight portions
Radix Peucedani 15 weight portion Fructus Atriplicis Sibiricaees 15 weight portion Radix Bupleuri 15 weight portions
Bulbus Fritillariae Cirrhosae 15 weight portion Rhizoma Cimicifugaes 15 weight portion Rhizoma Chuanxiongs 15 weight portions
Pericarpium Citri Reticulatae Viride 15 weight portion Radix Achyranthis Bidentataes 15 weight portion Radix Clematidis 15 weight portions
The Rhizoma Atractylodis 15 weight portion Cortexs Eucommiae 15 weight portion Radix Rehmanniae 15 weight portions
The Herba Asari 15 weight portion Radix Rehmanniaes Preparata 15 weight portion Rhizoma Anemarrhenaes 15 weight portions
Radix Polygalae 15 weight portion Radix Angelicae Sinensis 15 weight portion Herba Menthaes 15 weight portions
The Herba Artemisiae Scopariae 15 weight portion Cortex Dictamni 15 weight portion Rhizoma Atractylodis Macrocephalaes 15 weight portions
Semen Armeniacae Amarum 15 weight portion Rhizoma Et Radix Notopterygiis 15 weight portion Cortex Acanthopanciss 15 weight portions
The Rhizoma Pinelliae 15 weight portion Cortex Mori 15 weight portion Radix Angelicae Pubescentiss 15 weight portions
Ramulus Salicis Babylonicae 15 weight portion Caulis Akebiaes 15 weight portion Radix Sanguisorbaes 15 weight portions
Windproof 15 weight portions of Chinese toon branch 15 weight portion Ramulus Broussonetiae 15 weight portions
The Radix Astragali 15 weight portion Squama Maniss 15 weight portions.
3. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Radix Aconiti 7 weight portion Radix Aconiti Kusnezoffii 22 weight portion Scolopendras 7 weight portions
The Rhizoma Arisaematis 22 weight portion Rhizoma Gastrodiaes 7 weight portion Radixs Angelicae Dahuricae 22 weight portions
The black ginseng of Rhizoma Cyperi 7 weight portions 22 weight portion Fructus Gardeniaes 7 weight portions
The Fructus Aurantii 22 weight portion Radix Et Rhizoma Rhei 7 weight portion Radixs Linderae 22 weight portions
Radix Peucedani 7 weight portion Fructus Atriplicis Sibiricaees 22 weight portion Radix Bupleuri 7 weight portions
Bulbus Fritillariae Cirrhosae 22 weight portion Rhizoma Cimicifugaes 7 weight portion Rhizoma Chuanxiongs 22 weight portions
Pericarpium Citri Reticulatae Viride 7 weight portion Radix Achyranthis Bidentataes 22 weight portion Radix Clematidis 7 weight portions
The Rhizoma Atractylodis 22 weight portion Cortexs Eucommiae 7 weight portion Radix Rehmanniae 22 weight portions
The Herba Asari 7 weight portion Radix Rehmanniaes Preparata 22 weight portion Rhizoma Anemarrhenaes 7 weight portions
Radix Polygalae 22 weight portion Radix Angelicae Sinensis 7 weight portion Herba Menthaes 22 weight portions
The Herba Artemisiae Scopariae 7 weight portion Cortex Dictamni 22 weight portion Rhizoma Atractylodis Macrocephalaes 7 weight portions
Semen Armeniacae Amarum 22 weight portion Rhizoma Et Radix Notopterygiis 7 weight portion Cortex Acanthopanciss 22 weight portions
The Rhizoma Pinelliae 7 weight portion Cortex Mori 22 weight portion Radix Angelicae Pubescentiss 7 weight portions
Ramulus Salicis Babylonicae 22 weight portion Caulis Akebiaes 7 weight portion Radix Sanguisorbaes 22 weight portions
Windproof 7 weight portions of Chinese toon branch 7 weight portion Ramulus Broussonetiae 22 weight portions
The Radix Astragali 22 weight portion Squama Maniss 7 weight portions.
4. pharmaceutical composition as claimed in claim 1 is characterized in that the crude drug of this pharmaceutical composition consists of:
Radix Aconiti 20 weight portion Radix Aconiti Kusnezoffii 10 weight portion Scolopendras 20 weight portions
The Rhizoma Arisaematis 10 weight portion Rhizoma Gastrodiaes 20 weight portion Radixs Angelicae Dahuricae 10 weight portions
The black ginseng of Rhizoma Cyperi 20 weight portions 10 weight portion Fructus Gardeniaes 20 weight portions
The Fructus Aurantii 10 weight portion Radix Et Rhizoma Rhei 20 weight portion Radixs Linderae 10 weight portions
Radix Peucedani 20 weight portion Fructus Atriplicis Sibiricaees 10 weight portion Radix Bupleuri 20 weight portions
Bulbus Fritillariae Cirrhosae 10 weight portion Rhizoma Cimicifugaes 20 weight portion Rhizoma Chuanxiongs 10 weight portions
Pericarpium Citri Reticulatae Viride 20 weight portion Radix Achyranthis Bidentataes 10 weight portion Radix Clematidis 20 weight portions
The Rhizoma Atractylodis 10 weight portion Cortexs Eucommiae 20 weight portion Radix Rehmanniae 10 weight portions
The Herba Asari 20 weight portion Radix Rehmanniaes Preparata 10 weight portion Rhizoma Anemarrhenaes 20 weight portions
Radix Polygalae 10 weight portion Radix Angelicae Sinensis 20 weight portion Herba Menthaes 10 weight portions
The Herba Artemisiae Scopariae 20 weight portion Cortex Dictamni 10 weight portion Rhizoma Atractylodis Macrocephalaes 20 weight portions
Semen Armeniacae Amarum 10 weight portion Rhizoma Et Radix Notopterygiis 20 weight portion Cortex Acanthopanciss 10 weight portions
The Rhizoma Pinelliae 20 weight portion Cortex Mori 10 weight portion Radix Angelicae Pubescentiss 20 weight portions
Ramulus Salicis Babylonicae 10 weight portion Caulis Akebiaes 20 weight portion Radix Sanguisorbaes 10 weight portions
Windproof 20 weight portions of Chinese toon branch 20 weight portion Ramulus Broussonetiae 10 weight portions
The Radix Astragali 10 weight portion Squama Maniss 20 weight portions.
5. like the arbitrary described pharmaceutical composition of claim 1-4, it is characterized in that the conventional adjuvant on this pharmaceutical composition adding pharmaceutics is processed the exterior-applied formulation of clinical acceptance.
6. pharmaceutical composition as claimed in claim 5 is characterized in that said dosage form is black unguentum, ointment, emplastrum, cataplasma, rubber-emplastrum or powder.
7. like claim 1-4 or the application of 6 arbitrary described pharmaceutical compositions in the medicine of preparation treatment paralysis.
8. like the application of the arbitrary described pharmaceutical composition of claim 5 in the medicine of preparation treatment paralysis.
CN2010105124820A 2010-10-12 2010-10-12 Medicinal composition for treating paralysis and preparation method thereof Expired - Fee Related CN101953999B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105124820A CN101953999B (en) 2010-10-12 2010-10-12 Medicinal composition for treating paralysis and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105124820A CN101953999B (en) 2010-10-12 2010-10-12 Medicinal composition for treating paralysis and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101953999A CN101953999A (en) 2011-01-26
CN101953999B true CN101953999B (en) 2012-11-21

Family

ID=43481755

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105124820A Expired - Fee Related CN101953999B (en) 2010-10-12 2010-10-12 Medicinal composition for treating paralysis and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101953999B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103816402A (en) * 2014-03-25 2014-05-28 梁黎明 Traditional Chinese medicine composition for treating liver wind agitation

Also Published As

Publication number Publication date
CN101953999A (en) 2011-01-26

Similar Documents

Publication Publication Date Title
CN102091295B (en) Chinese medicinal composition for treating femoral head necrosis and preparation method thereof
CN103316324B (en) Traditional Chinese medicine foot-bathing liquid for treating rheumatoid disease
CN101612220B (en) External-application cream for treating osteoarthritis and preparation method thereof
CN103893639A (en) Traditional Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof
CN102274378B (en) Brain-strengthening and thrombosis-resisting pills for treating cerebrovascular diseases and preparation method thereof
CN106491928A (en) A kind of Synergistic treatment brachia plexus injury type cerebral palsy composite preparation
CN103768315A (en) Bone-setting plaster for setting bone and activating blood circulation
CN102872301B (en) Anti-rheumatism medicinal liquor and using method thereof
CN104383445A (en) Traumatic injury analgesic
CN103417774B (en) Traditional Chinese medicine and preparing method and application thereof
CN102961610B (en) Topical paste patch
CN101953999B (en) Medicinal composition for treating paralysis and preparation method thereof
CN104096022A (en) External use compound Chinese herbal preparation for treating ankylosing spondylitis and preparation method thereof
CN102366597A (en) Traditional Chinese medicine preparation for prevention and treatment of nervous depression
CN102430030B (en) Chinese medicinal composition for treating bone impediment
CN105617198A (en) Method for preparing medicinal liquor for treating wind-cold low back pain
CN101612380A (en) A kind of Chinese medicine composition for the treatment of chilblain and preparation method thereof
CN103285108B (en) Chinese medicinal composition treating lumbago
CN102600251A (en) Compound rheumatism-rehabilitating composite agent
CN101204533B (en) Yaotuhuiwei capsule combining anti-walk for prolapse of lumbar intervertebral disc
CN100478007C (en) Plaster for treating traumatic injuries and rheumatism, and its prepn. method
CN101406645A (en) Chinese medicinal composition for hyperosteogeny
CN100404065C (en) Externally-applied medicinal liquid for treating rheumatalgia and wound and its preparation
CN105194411A (en) Formula of traditional Chinese medicine for treating scapulobumeral periarthritis
CN106166181A (en) The local topical Traditional Chinese medicinal liquor for the treatment of arthralgia due to wind-cold-dampness disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121121

Termination date: 20141012

EXPY Termination of patent right or utility model